Currax Pharmaceuticals

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Key Events

Details

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

4 patent groups across drugs · Source: FDA Orange Book

DrugExpires

Regulatory

19823 events

FDAJan 1

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application NDA016987 (NDA)

FDAJan 1

Doxepin Hydrochloride — SINEQUAN

Application NDA016798 (NDA)

FDAJan 1

Doxepin Hydrochloride — SINEQUAN

Application NDA017516 (NDA)

19941 event

FDAApr 1

Doxepin Hydrochloride — ZONALON

Application NDA020126 (NDA)

20101 event

FDAMar 17

Doxepin Hydrochloride — SILENOR

Application NDA022036 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)